Pharma Automation Surge: How PLC Systems Are Revolutionizing Quality Control
On this page
Pharma Automation Surge: How PLC Systems Are Revolutionizing Quality Control
The Pharmaceutical Automation Revolution: Why PLC Systems Are Now Mission-Critical
Detail
The recent announcement that Rapid Micro Biosystems will participate in the KeyBanc Capital Markets Healthcare Forum signals a seismic shift in pharmaceutical manufacturing. As the industry grapples with regulatory pressures and quality control challenges, PLC-based automation systems are emerging as the backbone of modern pharmaceutical production.
Rapid Micro Biosystems, a leading life sciences technology company, is showcasing how their Growth Direct system brings quality control labs directly to the manufacturing floor. This represents more than just technological advancement, it's a fundamental rethinking of how pharmaceutical companies approach quality assurance, regulatory compliance, and operational efficiency.
The global pharmaceutical automation market is experiencing unprecedented expansion, driven by several key factors:
FDA 21 CFR Part 11 compliance requirements and updated ICH Q9 guidance on quality risk management are forcing manufacturers to adopt more robust automation solutions
The Inflation Reduction Act (IRA) and reduced profit margins are pushing companies toward efficiency gains through automation
Increasing complexity of biologics and biosimilars requires more sophisticated quality control systems
Pharmaceutical companies rank among the top three industries for highest average cost of data breaches, driving investment in secure automation infrastructure
Sourcing help
Send the BOM for one quote covering active stock, EOL stock and cross-references.
Need a quote for this part?
Send us the part number or article link — we will confirm price, availability and lead time.
